Response and Resistance to Menin Inhibitor in <i>UBTF</i> –Tandem Duplication AML-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response and Resistance to Menin Inhibitor in UBTF –Tandem Duplication AML

Published:2024-06-27 Issue:24 Volume:390 Page:2323-2325
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Tiong Ing Soo¹^ORCID,Ritchie David S.²,Blombery Piers¹

Affiliation:

1. Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

2. Royal Melbourne Hospital, Melbourne, VIC, Australia

Funder

Wilson Centre for Blood Cancer Genomics

National Health and Medical Research Council

Snowdome Foundation

Publisher

Massachusetts Medical Society

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMc2404110

Reference5 articles.

1. Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia

2. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

3. Acute myeloid leukemias with UBTF tandem duplications are sensitive to Menin inhibitors

4. Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML

5. MEN1 mutations mediate clinical resistance to menin inhibition

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP